GUIDO, MAURIZIO
 Distribuzione geografica
Continente #
NA - Nord America 1.861
EU - Europa 779
AS - Asia 52
OC - Oceania 2
SA - Sud America 1
Totale 2.695
Nazione #
US - Stati Uniti d'America 1.853
IE - Irlanda 573
IT - Italia 47
DE - Germania 34
CZ - Repubblica Ceca 25
SE - Svezia 19
SG - Singapore 17
BE - Belgio 16
CN - Cina 16
FI - Finlandia 13
GB - Regno Unito 11
CA - Canada 6
BG - Bulgaria 5
JP - Giappone 5
NL - Olanda 5
AT - Austria 4
IN - India 4
PL - Polonia 4
EE - Estonia 3
ES - Italia 3
IL - Israele 3
AU - Australia 2
FR - Francia 2
NO - Norvegia 2
RS - Serbia 2
AL - Albania 1
BN - Brunei Darussalam 1
BR - Brasile 1
DK - Danimarca 1
GL - Groenlandia 1
HK - Hong Kong 1
HR - Croazia 1
HU - Ungheria 1
ID - Indonesia 1
KZ - Kazakistan 1
LT - Lituania 1
LU - Lussemburgo 1
MD - Moldavia 1
MX - Messico 1
OM - Oman 1
PT - Portogallo 1
RO - Romania 1
SI - Slovenia 1
TR - Turchia 1
TW - Taiwan 1
UA - Ucraina 1
Totale 2.695
Città #
Dublin 565
Chandler 556
Jacksonville 139
Lawrence 82
Princeton 82
Wilmington 81
New York 71
Des Moines 70
Ashburn 69
Los Angeles 56
San Mateo 47
Ann Arbor 37
Falls Church 34
Boardman 23
Brno 18
Brussels 16
Norwalk 12
Rome 11
Singapore 11
Bremen 9
Munich 9
Hanover 7
Lappeenranta 7
Helsinki 6
Ravenna 6
Olomouc 5
Sofia 5
Stockholm 5
Tokyo 5
Pune 4
Tappahannock 4
Toronto 4
Vienna 4
Warsaw 4
Berlin 3
Edinburgh 3
Fairfield 3
Frankfurt am Main 3
Fremont 3
Houston 3
London 3
Madrid 3
Phoenix 3
Shanghai 3
Tallinn 3
Tel Aviv 3
Belgrade 2
Dallas 2
Fara San Martino 2
Florence 2
Francavilla al Mare 2
Hangzhou 2
Oggiono 2
Oslo 2
Prague 2
Rosendaal 2
Seattle 2
Washington 2
Adelaide 1
Assago 1
Atlanta 1
Bandar Seri Begawan 1
Beauharnois 1
Beijing 1
Birmingham 1
Borehamwood 1
Budapest 1
Buffalo 1
Canberra 1
Cardiff 1
Central 1
Charlotte 1
Chicago 1
Clearwater 1
Copenhagen 1
Council Bluffs 1
Glasgow 1
Istanbul 1
Jakarta 1
Las Vegas 1
Lisbon 1
Ljubljana 1
Manchester 1
Miami 1
Milan 1
Montreal 1
Muskegon 1
Nuuk 1
Odesa 1
Oral 1
Orlando 1
Paris 1
Pedreiras 1
Salalah 1
Secaucus 1
Shenzhen 1
Soledad de Doblado 1
St Louis 1
Taipei 1
Tampa 1
Totale 2.166
Nome #
Case report: incomplete Cauda Equina Syndrome following a caesarean section with spinal anaesthesia 55
Sex ratio at birth: causes of variation and narrative review of literature 49
COVID-19 and ART: the view of the Italian Society of Fertility and Sterility and Reproductive Medicine 47
Botulinum toxin in incontinent women with neurogenic bladder after failure with anticholinergic therapy, long-term results: a pilot study 47
ROLE OF VOCAL DISTRACTION ANALGESIA ON PAIN MANAGEMENT IN THE OFFICE HYSTEROSCOPY PROCEDURE: A RANDOMIZED CONTROLLED STUDY 43
Comparison of absorbable and permanent sutures for laparoscopic sacrocervicopexy: A randomized controlled trial 42
Effect of gonadotropin-releasing hormone agonist treatment on growth hormone responses in women with polycystic ovary syndrome 42
Using a 16-french resectoscope as an alternative device in the treatment of uterine lesions: A randomized controlled trial 42
Perimesencephalic Subarachnoid Hemorrhage in Pregnancy 42
DTC chemotherapy regimen is associated with higher incidence of premature ovarian failure in women of reproductive age with breast cancer 41
How metformin acts in PCOS pregnant women: Insights into insulin secretion and peripheral action at each trimester of gestation 40
Suppression and recovery of gonadotropin and steroid secretion by a gonadotropin-releasing hormone receptor antagonist in healthy women with normal ovulation versus women with polycystic ovary syndrome in the early follicular phase 39
Is the PCOS diagnosis solved by ESHRE/ASRM 2003 consensus or could it include ultrasound examination of the ovarian stroma? 39
AGEs-related dysfunctions in PCOS: evidence from animal and clinical research 38
Metformin vs myoinositol: which is better in obese polycystic ovary syndrome patients? A randomized controlled crossover study 37
Assessment of insulin resistance in lean women with polycystic ovary syndrome 37
Perinatal mental illness and autoimmune diseases: a qualitative sistematic review 37
The Impact of Metal Nanoparticles on Female Reproductive System: Risks and Opportunities 36
Administration of exogenous ghrelin in obese patients with polycystic ovary syndrome: effects on plasma levels of growth hormone, glucose, and insulin 36
Evidence of a disturbance of the hypothalamic-pituitary-adrenal axis in polycystic ovary syndrome: Effect of naloxone 36
Differentiation of spermatogenic cells during in-vitro culture of testicular biopsy samples from patients with obstructive azoospermia: Effect of recombinant follicle stimulating hormone 35
The effect of age on the ovarian response to gonadotropin and on pregnancy rate in polycystic ovary syndrome 35
Opioid blockade effect on insulin β-cells secretory patterns in polycystic ovary syndrome. Oral glucose load versus intravenous glucagon bolus 35
A first stage placental site trophoblastic tumor: a case report and review of literature 35
Endocrinology: Effect of opioid blockade on insulin metabolism in polycystic ovarian disease 34
Acute insulin response to intravenous glucagon in polycystic ovary syndrome 34
Effect of metformin on the growth hormone response to growth hormone-releasing hormone in obese women with polycystic ovary syndrome 33
Metformin improves endothelial function in normoinsulinemic PCOS patients: A new prospective 33
Differential androgen response to adrenocorticotropic hormone stimulation in polycystic ovarian syndrome: Relationship with insulin secretion 33
Effects of ghrelin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome 33
Naltrexone effect on pulsatile GnRH therapy for ovulation induction in polycystic ovary syndrome: A pilot prospective study 33
Second stimulation in the same ovarian cycle: an option to fully-personalize the treatment in poor prognosis patients undergoing PGT-A 33
The resting metabolic rate in women with polycystic ovary syndrome and its relation to the hormonal milieu, insulin metabolism, and body fat distribution: a cohort study 32
Carbon dioxide in office diagnostic hysteroscopy: An open question. A multicenter randomized trial on 1982 procedures 32
Alteration of ghrelin-neuropeptide Y network in obese patients with polycystic ovary syndrome: Role of hyperinsulinism 32
Drospirenone for the treatment of hirsute women with polycystic ovary syndrome: A clinical, endocrinological, metabolic pilot study 32
Erratum: Gonadotropin-releasing hormone agonist versus human chorionic gonadotropin as a trigger of ovulation in polycystic ovarian disease gonadotropin hyperstimulated cycles (Fertility and Sterility (1994) 62 (35- 41)) 32
Gonadotropin-releasing hormone agonist versus human chorionic gonadotropin as a trigger of ovulation in polycystic ovarian disease gonadotropin hyperstimulated cycles 32
Involvement of ovarian steroids in the opioid-mediated reduction of insulin secretion in hyperinsulinemic patients with polycystic ovary syndrome 32
Metformin effects on ovarian ultrasound appearance and steroidogenic function in normal-weight normoinsulinemic women with polycystic ovary syndrome: A randomized double-blind placebocontrolled clinical trial 31
How to improve MRI accuracy in detecting deep infiltrating colorectal endometriosis: MRI findings vs. laparoscopy and histopathology 31
Changes in luteinizing hormone and insulin secretion in polycystic ovarian syndrome 31
Expectant management may reduce overtreatment in women affected by unexplained infertility confirmed by diagnostic laparoscopy 30
Preconceptional and gestational evaluation of insulin secretion in patients with polycystic ovary syndrome 30
A pilot study of the long-term effects of acipimox in polycystic ovarian syndrome 30
Effect of corticotropin-releasing factor on the pituitary-ovary axis in human luteal phase 30
Influence of body mass on the hypothalamic-pituitary-adrenal-axis response to naloxone in patients with polycystic ovary syndrome 30
Is there a role for soy isoflavones in the therapeutic approach to polycystic ovary syndrome? Results from a pilot study 30
Ethinylestradio-chlormadinone acetate combination for the treatment of hirsutism and hormonal alterations of normal-weight women with polycystic ovary syndrome: Evaluation of the metabolic impact 29
The Impact of Insulin Secretion on the Ovarian Response to Exogenous Gonadotropins in Polycystic Ovary Syndrome 29
Metformin treatment does not affect total leptin levels and free leptin index in obese patients with polycystic ovary syndrome 29
Fertility preservation methods in breast cancer 29
Longitudinal metabolic observation of metformin effects during pregnancy in hyperinsulinemic women with polycystic ovary syndrome: A case report 29
Vaginal mesh exposure after laparoscopic sacrocervicopexy performed with permanent or absorbable sutures 29
Selective effects of pioglitazone on insulin and androgen abnormalities in normo- and hyperinsulinaemic obese patients with polycystic ovary syndrome 28
Sexual Function following Laparoscopic versus Transvaginal Closure of the Vaginal Vault after Laparoscopic Hysterectomy: Secondary Analysis of a Randomized Trial by the Italian Society of Gynecological Endoscopy Using a Validated Questionnaire 27
Role of opioid tone in the pathophysiology of hyperinsulinemia and insulin resistance in polycystic ovarian disease 27
Impact of insulin and body mass index on metabolic and endocrine variables in polycystic ovary syndrome 27
Follicular loss in endoscopic surgery for ovarian endometriosis: Quantitative and qualitative observations 27
Postmenarchal Down's syndrome: A theoretical model of growth hormone action on ovarian function 27
Somatostatin treatment reduces the exaggerated response of adrenocorticotropin hormone and cortisol to corticotropin-releasing hormone in polycystic ovary syndrome 26
Effect of pioglitazone treatment on the adrenal androgen response to corticotrophin in obese patients with polycystic ovary syndrome 26
Hypothalamic-pituitary-adrenal axis sensitivity to opioids in women with polycystic ovary syndrome 26
Position paper on prevention of surgical site infections in obstetric and gynecological surgery 26
DTC chemotherapy regimen is associated with higher occurrence of premature ovarian failure in women of reproductive age with breast cancer 26
The Role of Anti-Müllerian Hormone in the Characterization of the Different Polycystic Ovary Syndrome Phenotypes 25
Hyperinsulinemia in PCOS. Possible role in the determination of the ovary response to gonadotrophins 25
Clinical efficacy andmetabolic impact of two different dosages of ethinyl-estradiol in association with drospirenone in normal-weight women with polycystic ovary syndrome: A randomized study 25
Favorable conception and pregnancy involving a male patient affected by chronic myeloid leukemia while taking dasatinib 25
Human spermatogenesis in vitro: Respective effects of follicle- stimulating hormone and testosterone on meiosis, spermiogenesis, and sertoli cell apoptosis 25
The use of different size-hysteroscope in office hysteroscopy: Our experience 24
The hypothalamic-pituitary-luteal axis in women: effects of long-term orally active opioid antagonist (naltrexone) administration 24
Clinical, obstetric and perinatal outcomes after vitrified-warmed euploid blastocyst transfer are independent of cryo-storage duration 24
Laparoscopic sacrocolpopexy versus pelvic organ prolapse suspension for surgical management of pelvic organ prolapse: a retrospective study 23
Sonographic features of pelvic tuberculosis mimicking ovarian-tubal-peritoneal carcinoma 22
The metabolic status modulates the effect of metformin on the antimullerian hormone-androgens-insulin interplay in obese women with polycystic ovary syndrome 22
Pioglitazone reduces the adrenal androgen response to corticotropin-releasing factor without changes in ACTH release in hyperinsulinemic women with polycystic ovary syndrome 22
Evaluation of ovarian and adrenal sources of androgens in women with polycystic ovary syndrome: Dexamethasone and GnRH-agonist administration 21
The accuracy of prenatal cell-free DNA screening for sex chromosome abnormalities: a systematic review and meta-analysis 20
Shining light in a dark landscape: MRI evaluation of unusual localization of endometriosis 20
The link between metabolic features and TSH levels in polycystic ovary syndrome is modulated by the body weight: An euglycaemic-hyperinsulinaemic clamp study 20
Role of opioid antagonists in the treatment of women with glucoregulation abnormalities 20
Effect of the opioid blockade on the feeding-induced growth hormone response to growth hormone-releasing hormone in women with polycystic ovary syndrome 19
Nerve-Sparing Laparoscopic Colposacropexy Using a Percutaneous Surgical System: A Case Report 18
Risk Assessment Model for Complications in Minimally Invasive Hysterectomy: A Pilot Study 17
Endocrinology: Differential androgen response to adrenocorticotrophin hormone stimulation and effect of opioid antagonist on insulin secretion in polycystic ovarian syndrome 17
Asymptomatic postmenopausal endometrial thickening: a comparison between transvaginal ultrasound and hysteroscopy in the diagnosis of intracavitary uterine pathologies 16
Metaphase‑II oocyte competence is unlinked to the gonadotrophins used for ovarian stimulation: a matched case–control study in women of advanced maternal age 16
How should the best human embryo in vitro be? Current and future challenges for embryo selection 15
Prospective multicentre Italian pregnancy cohort study (SIMPLE) on the associations of maternal first trimester SIMPLE nutritional score with early placental function markers and pregnancy outcomes 13
Progesterone: The Key Factor of the Beginning of Life 12
TOPICAL HAEMOSTATICS AND SEALANTS IN GYNAECOLOGICAL AND OBSTETRIC 3 SURGERY: STATE OF THE ART 12
The Perception of the Quality of Professional Healthcare Assistance for the Management of Endometriosis: Findings from a National Survey in Italy 12
Sonographic characteristics of ovarian Leydig cell tumor 12
Conservative management of preterm premature rupture of membranes < 30 weeks of gestational age: Effectiveness of clinical guidelines implementation strategies 11
Pre-eclampsia: From Etiology and Molecular Mechanisms to Clinical Tools. A Review of the Literature 10
The Accuracy of Third-Trimester Ultrasound in Predicting Large for Gestational Age or Macrosomic Fetuses in Diabetic and Non-Diabetic Pregnant Women: A Systematic Review and Meta-Analysis 10
Conservative Management and Ultrasound Follow-Up of Parasitic Myoma: Our Experience and Literature Review 9
Ultrasound Features and Clinical Outcome of Patients with Ovarian Masses Diagnosed during Pregnancy: Experience of Single Gynecological Ultrasound Center 9
Maternal and fetal outcomes of intraplacental choriocarcinoma complicated by fetomaternal hemorrhage: a systematic review 9
Totale 2.819
Categoria #
all - tutte 18.140
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.140


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021265 0 0 0 0 0 0 0 70 75 2 117 1
2021/2022425 0 4 3 9 32 35 9 32 41 32 37 191
2022/20231.675 122 116 35 162 78 194 27 126 699 11 83 22
2023/2024480 71 17 43 34 33 110 22 35 3 51 22 39
2024/202519 19 0 0 0 0 0 0 0 0 0 0 0
Totale 2.864